Objective:

To explore the use of scleral lenses and filling solutions for managing dry eye and ocular surface disease, emphasizing their importance in symptom control.

Approach:

Key Findings:

• 67% of patients use nonpreserved saline vials for scleral lenses.
• 41% of practitioners recommend nebulizer saline, while 37% recommend specific scleral lens filling solutions.
• Adding artificial tears to saline improves symptoms compared to saline alone.
• Autologous serum in the lens reservoir can aid in healing persistent epithelial defects.
• Nonpreserved cyclosporine in the lens reservoir improves OSDI scores and ocular surface staining.

Interpretation:

The choice of filling solution and potential additives are crucial for optimizing scleral lens therapy in dry eye patients, impacting their quality of life.

Limitations:

• The study does not address long-term effects of various filling solutions, which may limit understanding of their sustained efficacy.
• Limited data on the efficacy of newer filling solutions compared to traditional options may hinder informed clinical decisions.

Conclusion:

Tailoring the filling solution and considering additives can significantly enhance symptom control in dry eye patients using scleral lenses, highlighting the need for personalized treatment strategies.

Sources:

• Schornack et al. (2023)
• Tan et al. (2022)
• Nakhla et al. (2024)
Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.